Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.

Cardiovasc Diabetol · 2021 · PMC8684205 · PMID 34920733

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, two of the metabolites showing significant increase after glimepiride treatment (C16:1, methionine), showed a trend of positive correlation with the BMI change, being potentially related to the change in BMI.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.